Longfellow Investment Management’s Avidity Biosciences RNAM Stock Holding History

Longfellow Investment Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,072	Closed	-$77.3K	–	271
2025 Q4	$77.3K	Buy	+1,072	New	+$69.2K	0.02%	145

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Longfellow Investment Management's RNAM Position: Q1 2026 in Review

Longfellow Investment Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1,072 shares — an estimated $77.3K sold.

Longfellow Investment Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $77.3K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Longfellow Investment Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Longfellow Investment Management sold 1,072 Avidity Biosciences shares in Q1 2026, an estimated $77.3K.
Longfellow Investment Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Longfellow Investment Management's Avidity Biosciences position peaked at $77.3K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Longfellow Investment Management's 13F filing for Q1 2026, filed 12 May 2026.